for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Novavax Inc - Has Already Initiated Development Of A New Recombinant Spike Protein Based On The Known Genetic Sequence Of B.1.1.529

Nov 26 (Reuters) - Novavax Inc:

* NOVAVAX INC - HAS ALREADY INITIATED DEVELOPMENT OF A NEW RECOMBINANT SPIKE PROTEIN BASED ON THE KNOWN GENETIC SEQUENCE OF B.1.1.529

* NOVAVAX - WILL HAVE NEW RECOMBINANT SPIKE PROTEIN BASED ON KNOWN GENETIC SEQUENCE OF B.1.1.529 READY FOR TESTING, MANUFACTURING WITHIN NEXT FEW WEEKS

* NOVAVAX - RECENT DATA FROM PHASE 2 TRIAL LEAD US TO BELIEVE THAT OUR VACCINE IS LIKELY TO PROVIDE PROTECTION AGAINST NEW, EMERGING COVID-19 VARIANTS Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up